B2M and autoimmune polyendocrinopathy: The difference observed in B2M-CIC levels resulted in a higher prevalence of B2M-CIC-positive patients with isolated gestational morbidity (44.8%) in comparison with patients with isolated thrombosis (29.6%, p=0.023) and mixed APS (25.0%, p=0.042) (Supplementary Table S5).